Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms
Ital J Dermatol Venerol
.
2022 Apr;157(2):201-202.
doi: 10.23736/S2784-8671.21.06993-0.
Epub 2021 May 13.
Authors
Giovanni Paolino
1
2
,
Giuseppe A Ramirez
3
4
,
Mona R Yacoub
3
,
Nathalie Rizzo
5
,
Teresa Grieco
6
,
Luca Moroni
3
4
,
Enrica P Bozzolo
3
,
Matteo R DI Nicola
7
,
Lorenzo Dagna
3
4
,
Santo R Mercuri
7
Affiliations
1
Clinic of Dermatologic, Sapienza University, Rome, Italy - paolino.giovanni@hsr.it.
2
Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy - paolino.giovanni@hsr.it.
3
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milan, Italy.
4
Vita-Salute San Raffaele University, Milan, Italy.
5
Unit of Surgical Pathology, IRCCS San Raffaele Hospital, Milan, Italy.
6
Clinic of Dermatologic, Sapienza University, Rome, Italy.
7
Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
PMID:
33982555
DOI:
10.23736/S2784-8671.21.06993-0
No abstract available
MeSH terms
Antibodies, Monoclonal, Humanized / adverse effects
Humans
Lupus Erythematosus, Cutaneous* / chemically induced
Substances
Antibodies, Monoclonal, Humanized
dupilumab